Statement CSAT on Consensus EAS 2021: Triglyceride-rich lipoproteins and their remnants –⁠ metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies

Czech version

Authors: Michal Vrablík; Vladimír Bláha; Renata Cífková; Tomáš Freiberger; David Karásek; Pavel Kraml; Jan Piťha; Hana Rosolová; Vladimír Soška; Tomáš Štulc; Zuzana Urbanová Za Výbor Čsat; Jana Mašková
Published in: AtheroRev 2022; 7(3): 130-139
Category: Guidelines

Sources

1. Ginsberg HN, Packard CJ, Chapman MJ et al. Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society. Eur Heart J 2021; 42(47): 4791–4806. Dostupné z DOI: <http://doi: 10.1093/eurheartj/ehab551>.

Labels

Angiology Diabetology Internal medicine Cardiology General practitioner for adults

Editorialy

Newer possibilities of slowing the development of chronic kidney disease and the role of dapagliflozin

Bempedoic acid – a new drug to lower LDL-cholesterol level

The importance of diet therapy and the correct regimen in familial hypercholesterolemia

PACMAN-AMI trial: review of endpoints

What have imaging studies with evolocumab yielded?

Profesor Zdeněk Zadák pětaosmdesátiletý!

Research on remarkable articles from international literature

XXXVI. konference o hyperlipoproteinemiích – Šobrův den 2022

Article was published in

Athero Review

2022 Issue 3